M T Tacconi

Author PubWeight™ 10.22‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Piracetam: physiological disposition and mechanism of action. Adv Neurol 1986 0.90
2 Lowering of blood ketone bodies induced by drugs preventing free fatty acid mobilization. Experientia 1966 0.84
3 Role of surfactant in chronic obstructive pulmonary disease: therapeutic implications. Respiration 1992 0.83
4 Some aspects of the effect of nicotine on plasma FFA and tissue triglycerides. Pharmacology 1972 0.79
5 A novel pharmacological approach for paraquat poisoning in rat and A549 cell line using ambroxol, a lung surfactant synthesis inducer. Food Chem Toxicol 1992 0.78
6 Fate of 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET18-OME) in malignant cells, normal cells, and isolated and perfused rat liver. Drug Metab Dispos 1995 0.77
7 Accumulation and metabolism of uneven fatty acids present in single cell protein. Toxicol Lett 1980 0.77
8 Peripheral benzodiazepine receptor ligands in rat liver mitochondria: effect on cholesterol translocation. Eur J Pharmacol 1995 0.76
9 Plasma and platelet lipid composition and platelet aggregation by arachidonic acid in women on the pill. Thromb Haemost 1981 0.76
10 Caffeine disposition and effects in young and one-year old rats. J Pharm Pharmacol 1980 0.76
11 Peripheral benzodiazepine receptor ligands in rat liver mitochondria: effect on 27-hydroxylation of cholesterol. Eur J Pharmacol 1996 0.76
12 Adriamycin causes hyperlipemia as a consequence of nephrotoxicity. Toxicol Lett 1983 0.76
13 Biochemical analysis of myelin lipids and proteins in a model of methyl donor pathway deficit: effect of S-adenosylmethionine. Exp Neurol 1999 0.76
14 Proceedings: The disposition of l-(3-H) - noradrenaline by the isolated epididymal fat pad of the rat and the effect of antilipolytic agents. Br J Pharmacol 1974 0.75
15 A fast atom bombardment-mass spectrometric method to quantitate lysophosphatidylserine in rat brain. J Lipid Res 1989 0.75
16 Effect of cell density on cytotoxicity of ether lipid analogues in variants of B16 murine melanoma. Lipids 1993 0.75
17 Reye syndrome model in rats: protection against liver abnormalities by L-carnitine and acetyl-L-carnitine. J Pharmacol Exp Ther 1995 0.75
18 Synthetic ether lipids fluidizing action and cell membrane lipid composition: a commentary note. Int J Cancer 1992 0.75
19 [Incorporation of labeled phospholipids in Eustachian tube surfactant]. Acta Otorhinolaryngol Ital 1987 0.75
20 Effect of ambroxol on rabbit eustachian tube surfactant. ORL J Otorhinolaryngol Relat Spec 1992 0.75
21 Intraluminal inflammation in the airways of patients with chronic bronchitis after treatment with Ambroxol. Monaldi Arch Chest Dis 1995 0.75
22 Distribution of fenfluramine in normal and obese mice. Int J Obes 1978 0.75
23 Effect of some drugs on free fatty acids and triglycerides in plasma and tissues. Adv Exp Med Biol 1972 0.75
24 Comparison of hexachlorobenzene-induced alterations of microsomal membrane composition and monooxygenase activity in male and female rats. Toxicology 1987 0.75
25 Fluorescence polarization changes with gestational age in amniotic fluid of rabbit and guinea pig. Exp Lung Res 1990 0.75
26 Physiological disposition of oral piracetam in Sprague-Dawley rats. J Pharm Pharmacol 1984 0.75
27 Increased metabolism of metyrapone in rats pretreated with diphenylhydantoin or phenobarbital. Endocrinology 1969 0.75
28 Effect of carnitine on heart alterations caused by tricyclic antidepressants. J Pharm Pharmacol 1981 0.75
29 Haloperidol and trifluperidol in rat adipose tissue. Rev Eur Etud Clin Biol 1972 0.75
30 Effect of piribedil and its metabolite, S584, on brain lipid peroxidation in vitro and in vivo. Eur J Pharmacol 1997 0.75
31 Triglyceride accumulation in liver. Nature 1966 0.75
32 The effect of caloric restriction on a rat model of aging: biological, pathological, biochemical and behavioral characterization. Aging (Milano) 1991 0.75
33 A new method for the determination of metyrapone in plasma and tissues. J Chromatogr 1969 0.75
34 Phospholipid composition, phosphoinositide metabolism and metastatic capacity in murine melanoma B16 variants at different stages of growth. Melanoma Res 1992 0.75
35 Reye's and Reye-like syndromes, drug-related diseases? (causative agents, etiology, pathogenesis, and therapeutic approaches). Drug Metab Rev 1995 0.75
36 Disaturated phosphatidylcholine in rabbit eustachian tube surfactant. ORL J Otorhinolaryngol Relat Spec 1990 0.75
37 Protection against acute paraquat toxicity by ambroxol. Cytotechnology 1991 0.75
38 Effect of a contraceptive steroid combination of the "serum activation" of lipoprotein lipase in rats. Biochem Pharmacol 1978 0.75
39 Modulation of fibrinolytic response to venous occlusion in humans by a combination of low-dose aspirin and n-3 polyunsaturated fatty acids. Arterioscler Thromb 1992 0.75
40 Supplementation-induced changes in polyunsaturated fatty acid membrane and plasma composition do not modify mononuclear cell procoagulant activity. Thromb Res 1993 0.75